Change of Toll Like Receptor 4 Expression in Blood Mononuclear Cells of Patients with Metabolic Syndrome
Author:
Affiliation:

1.Department of Clinical Laboratory, ;3.Department of Cardiology, The Second Affiliated Hospital of Xuzhou Medical College, Xuzhou, Jiangsu 221006;2.Xuzhou Medical College, Xuzhou, Jiangsu 221002, China)

Clc Number:

R5

  • Article
  • | |
  • Metrics
  • |
  • Reference [16]
  • |
  • Related
  • |
  • Cited by
  • | |
  • Comments
    Abstract:

    Aim To compare the expression of Toll like receptor 4(TLR4) in blood mononuclear cells and plasma high-sensitivity C-reactive protein (hs-CRP) between metabolic syndrome (MS) patients and simple hypertensive patients. Methods There were 62 EH patients and 45 patients with MS. The TLR4 positive rate in blood mononuclear cells was detected by flow cytometry. We also detected the plasma hs-CRP of the patiens. Single factor analysis was performed on TLR4, hs-CRP and other observation indexes (age, sex, total cholesterol (TC), triglyceride (TG), high density lipoprotein (HDL), low density lipoprotein (LDL), fasting blood glucose (FBG) and glycated hemoglobin (HbA1c)), and then multi-factor regression analysis was also performed. Results TLR4 and hs-CRP were statistically significant between MS group (5.7%±1.2% and 5.6±0.9 mg/L) and EH group (5.3%±0.9% and 5.0±0.8 mg/L) (t values were -3.274, -2.225, P values were 0.028, 0.01); Single factor analysis showed that TLR4 was positively correlated with TC, LDL, HbA1c, FBG,2-hour postprandial blood glucose (2hPBG) and hs-CRP (P<0.05), and hs-CRP was positively correlated with TC, LDL, HbA1c, FBG,2hPBG, TLR4 (P<0.05); Meanwhile, multi-factor regression analysis showed that hs-CRP and HbA1c were the most significant factors which affected TLR4(β values were 0.745,0.244, P values were 0.000,0.004), and TLR4 was the most significant factor which affected hs-CRP (β=0.943, P=0.000). Conclusion It is MS patients that have higher TLR4 positive rate in mononuclear cells and plasma hs-CRP compared with EH patients. TLR4 positive rate and plasma hs-CRP levels of MS patients are positively correlated. And TLR4 may be involved in the development and progression of MS.

    Reference
    [1] Fu J, Prasad HC.Changing epidemiology of metabolic syndrome and type 2 diabetes in Chinese youth.Curr Diab Rep, 2014, 14(1):447.
    [2] Prclboiu L, Popa S, Puiu I, et al.The metabolic syndrome-new and old data.Rom J Intern Med, 2010, 48(2):193-203.
    [3] Liu Y, Yin H, Zhao M, et al.TLR2 and TLR4 in autoimmune diseases:a comprehensive review .Clin Rev Allergy Immunol, 2014, 47(2):136-147.
    [4] 中国高血压防治指南修订委员会.中国高血压防治指南2010.中华高血压杂志, 2011, 19(8):701-743.
    [5] 中国成人血脂异常防治指南制订联合委员会.中国成人血脂异常防治指南.中华心血管病杂志, 2007, 35(5):390-419.
    [6] Avogaro A.Insulin resistance:trigger or concomitant factor in the metabolic syndrome.Panminerva Med, 2006, 48(1):3-12.
    [7] Roberts CK, Hevener AL, Barnard RJ.Metabolic syndrome and insulin resistance:underlying causes and modification by exercise training.Compr Physiol, 2013, 3(1):1-58.
    [8] Alemany M.Relationship between energy dense diets and white adipose tissue inflammation in metabolic syndrome.Nutr Res, 2013, 33(1):1-11.
    [9] Hopps E, Noto D, Caimi G, et al.A novel component of the metabolic syndrome:the oxidative stress.Nutr Metab Cardiovasc Dis, 2010, 20(1):72-77.
    [10] Fuentes E, Guzmán-Jofre L, Moore-Carrasco R, et al.Role of PPARs in inflammatory processes associated with metabolic syndrome.Mol Med Rep, 2013, 8(6):1 611-616.
    [11] Purkayastha S, Cai D.Neuroinflammatory basis of metabolic syndrome.Mol Metab, 2013, 2(4):356-63.
    [12] Corrado E, Rizzo M, Aluigi L, et al.Prediction of vascular events in subjects with subclinical atherosclerosis and the metabolic syndrome:the role of markers of inflammation.Int Angiol, 2012, 31(3):219-226.
    [13] Medzhitov R, Preston-Hurlburt P, Janeway CA Jr.A human homoogue of the drosophia Toll protein signals activation of adaptive immunity.Nature, 1997, 388(6640):394-397.
    [14] Gianchecchi E, Fierabracci A.Gene/environment interactions in the pathogenesis of autoimmunity:New insights on the role of Toll-like receptors.Autoimmun Rev, 2015, 14(11):971-983.
    [15] Alexoudi I, Kapsimali V, Vaiopoulos A, et al.Toll-like receptors pathways implication in common autoimmune diseases and therapeutic perspectives.G Ital Dermatol Venereol, 2015, 150(2):255-260.
    [16] Schenk S, Saberi M, Olefsky JM.Insulin sensitivity:modulation by nutrients and inflammation.J Clin Invest, 2008, 18 (9):2 992-3 002.
    Related
    Cited by
Get Citation

LI Xiao-Hui, SHA Ting, PENG Cheng, QI Chun-Mei, LI Yong. Change of Toll Like Receptor 4 Expression in Blood Mononuclear Cells of Patients with Metabolic Syndrome[J]. Editorial Office of Chinese Journal of Arteriosclerosis,2016,24(3):273-276.

Copy
Share
Article Metrics
  • Abstract:1183
  • PDF: 964
  • HTML: 0
  • Cited by: 0
History
  • Received:May 15,2015
  • Revised:November 21,2015
  • Online: April 15,2016
Article QR Code